Elise Brownell
CIK: 0002008042
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IBO
IMPACT BIOMEDICAL INC.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Brownell Elise
Brownell Elise (SEC CIK 0002008042) files insider reports with the SEC as Director of IMPACT BIOMEDICAL INC. (IBO).
Signal8 holds 1 ownership filing by Brownell Elise, a Form 3, filed on Sep 16, 2024. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Brownell Elise's filings is in HOUSTON, TX.
Other insiders filing for IMPACT BIOMEDICAL INC. (IBO)
- DSS, INC., 10% Owner
- Macko Todd D, Chief Financial Officer
- Grady Jason, Director
- Chan Heng Fai Ambrose, 10% Owner
- Heuszel Frank D, Chief Executive Officer
- Keene David K, Director